Ceat’s Performance Analyzed
Ceat, a leading Indian tyre maker, had a really good third quarter (Q3) in the year 2026. Their profits jumped significantly – up 60% – reaching Rs 155.77 crore. This is a big increase compared to the previous year’s Q3, where they made Rs 97.11 crore. Revenue also went up by 26%, showing that more people are buying their tyres.
Key Points
- Strong profit growth: Net profit increased by 60.4%.
- Revenue increased: Sales rose 25.97% to Rs 4.157 billion.
- Operating margins improved: EBITDA margin reached 13.7%.
- Capacity expansion planned: Adding 35 lakh tyres annually by 2028.
- Investment planned: Rs 1,314 crore investment for expansion projects.
- Growth outlook positive: Expects continued growth and strong results.
Financial Highlights
The company made a profit before taxes of Rs 218.34 crore, which is up 71% compared to last year. This improvement was driven by making more money selling tyres and smart financial decisions. They also had some extra money from selling things that weren’t directly related to their main business (called “exceptional items”).
Capacity and Expansion
Ceat already makes about 95 lakh tyres each year. They’re planning to add another 35 lakh tyres, which will help them meet growing demand. This expansion will cost around Rs 1,314 crore and will be paid for using their own money and some borrowing.
Looking Ahead
The CEO, Arnab Banerjee, thinks things will continue to go well. He’s happy with the growth and believes the company will have a strong finish to the year. The CFO, Kumar Subbiah, pointed out that lower taxes and smart business choices helped improve their profits.
Ceat was founded in 1958 and is part of the RPG Enterprises group. They make tyres for motorcycles, cars, trucks, and other vehicles, and they sell them both in India and around the world. Their stock price was down slightly on the stock market, but overall, the company is doing very well.
“The positive momentum to sustain in the coming quarter and help us close the year strongly.” – Arnab Banerjee, MD & CEO, CEAT
